Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101538542B reveals a novel Pseudomonas esterase for high-purity mandelic acid. This biocatalytic route offers significant cost reduction and supply chain reliability for chiral intermediates.
Patent CN110483388A reveals high-yield synthesis for nicotinic acid derivatives offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112041298A details a safe, efficient route for aromatic nitriles via Willgerodt rearrangement. Reduces sulfur impurities and avoids toxic cyanides for pharma intermediates.
Patent CN102093399B reveals stable boronation reagent synthesis. Offers cost reduction and supply reliability for high-purity pharmaceutical intermediates manufacturing.
Novel patent CN120097853A enables efficient 5-ALA HCl production. Low cost, green process, reliable supply chain for pharmaceutical intermediates.
Novel one-pot Grignard method for alkyl phenylboronic acid reduces cost and time. Ideal for high-purity pharmaceutical and agrochemical intermediate manufacturing.
Patent CN103687489A reveals a safer, scalable route for 5-azaspiro[2.4]heptane-6-carboxylic acid, eliminating pyrophoric reagents for reliable HCV inhibitor supply.
Novel salt formation method removes dicarboxylic acid impurity ensuring high purity and yield for scalable antihypertensive drug manufacturing.
Patent CN101134943B reveals a novel Alcaligenes strain for >99.9% e.e. mandelic acid. Discover cost-effective biocatalytic solutions for pharmaceutical manufacturing.
Patent CN116675671A details high-yield amide synthesis suppressing by-products for cost reduction in agrochemical intermediate manufacturing and supply chain reliability.
Patent CN110004119B discloses a thermostable epsilon-ketoester reductase mutant enabling efficient synthesis of (R)-alpha-lipoic acid precursors with reduced catalyst loading and enhanced stability.
Patent CN113801045A details a novel Pd-catalyzed carbonylation route for 2-nitro-4-methylsulfonylbenzoic acid, offering safer, high-purity production for agrochemical supply chains.
Patent CN102317248A details an efficient route for (S)-3-cyclohexene-1-carboxylic acid, a key FXa inhibitor intermediate, offering significant cost and supply chain advantages.
Patent CN108069882A reveals continuous catalytic hydrogenation for anthranilic acid. Enhances purity and supply chain reliability for dye manufacturers significantly.
Patented chiral resolution process ensures high purity S-tetrahydro-2-furoic acid. Cost-effective manufacturing and reliable supply chain for global pharmaceutical partners.
Patent CN112359036B discloses engineered nitrilase mutants for efficient synthesis of pregabalin chiral intermediates, offering significant cost reduction in API manufacturing.
Patent CN115925534B reveals a pH-controlled extraction method achieving over 99% purity. This breakthrough offers significant cost reduction and supply chain reliability for global buyers.
Patent CN113480589B details a novel DMAP salt method for UDCA purification ensuring high yield and purity for reliable pharmaceutical intermediate supply chains.
Novel Strecker synthesis route for high-purity 2-aminobutyric acid. Reduces cost and impurities for Levetiracetam production via scalable n-propanal pathway.
Novel Pd-Pt-Zn catalyst enables 98% CHDA selectivity. Reduces decarboxylation. Ideal for reliable fine chemical intermediate supplier partnerships.